参考文献/References:
[1] FIRESTEIN G S.凯里风湿病学[M].8版.栗占国,唐福林,译.北京:北京大学医学出版社,2011:1619-1672.
[2] 张思恒,董晓梅,叶云凤,等.广州地区15岁及以上人群骨关节炎流行病学特征及危险因素分析[J].中华疾病控制杂志,2015,19(1):9-12.
[3] 施杞,王和鸣,中医骨伤科临床研究[M].北京:人民卫生出版社,2009:329-330.
[4] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中华骨质疏松和骨矿盐疾病杂志,2017,10(5):413-443.
[5] 李贺伟,王勇,魏优秀,等.血清MMP-3、RANK、RANKL、OPG水平诊断早期类风湿关节炎及骨关节损伤的价值[J].临床和实验医学杂志,2017,16(20):2026-2030.
[6] 李强,任慧萌.老年膝关节退行性骨关节病患者骨强度与骨密度的相关性[J].中国老年学杂志,2014,34(7):1837-1839.
[7] 侯桑怡,朱怀仕.膝关节退行性骨关节病X线与CT的影像学表现的探讨[J].中国医药科学,2018,8(3):177-179.
[8] 曾展鹏,戴才锋,郑伟杰,等.超声骨密度筛查膝关节骨性关节炎患者骨质疏松症的效果[J].实用医学杂志,2018,34(2):243-246.
[9] 杨再英,王福科,李平,等.骨质疏松症对骨性关节炎发病机制的影响[J].昆明医科大学学报,2016,37(4):91-94.
[10] 胡海澜,凌龙,何敏辉,等.绝经后不同骨关节退行性疾病与骨质疏松程度的相关性研究[J].中国骨质疏松杂志,2017,23(5):623-626.
[11] 梁晓红.跟骨定量超声筛查老年女性膝骨性关节炎患者骨质疏松的相关性研究[J].中华全科医学,2017,15(11):1891-1893.
[12] 杨伟铭,赵彩琼,潘三元,等.膝骨性关节炎患者膝关节局部骨密度的差异性研究[J].中国骨质疏松杂志,2017,23(6):772-777.
[13] REN Y,TAN B,YAN P,et al.Association between polymorphisms in the estrogen receptor alphagene and osteoaritis susceptibility:a meta-analysis[J].BMC Musculoskelet Disord,2015,16(1):44-53.
[14] 张海林,孙惠清,倪卓民,等.绝经后妇女膝关节骨性关节炎和骨质疏松症发生率关系[J].中国骨质疏松杂志,2016,22(4):463-465.
[15] LIAN G,CHEN M,YUE P,et al.Effect of warm-needle moxibustion on expression of transfer growth factor-β1 and insulin-like growth factor Ⅰ in knee cartilage of rabbits with knee osteoarthritis[J].Acupuncture Research,2015,40(3):229-232.
[16] LIU Y,GE J P,CHEN D Y,et al.Osteoprotegerin deficiency leads to deformation of the articular cartilage in femoral head[J].Journal of Molecular Histology,2016,47(5):475-483.
[17] MINATANI A,UCHIDA K,INOUE G,et al.Activation of calcitonin generelated peptide signaling through the prostaglandin E2-EP1/EP2/EP4 receptor pathway in synovium of knee osteoarthritis patients[J].Journal of Orthopaedic Surgery and Research,2016,11(1):117-124.
[18] ZENG J Z,MA L F,MENG H,et al.(5R)-5-hydroxytriptolide(LLDT-8)prevents collagen-induced arthritis through OPG/RANK/RANKL signaling in a rat model of rheumatoid arthritis[J].Exp Ther Med,2016,12(5):3101-3106.
[19] HAQUE BHUYAN M Z,TAMURA Y,SONE E,et al.The intra-articular injection of RANKL-binding peptides inhibits cartilage degeneration in a murine model of osteoarthritis[J].Journal of Pharmacological Sciences,2017,134(2):124-130
[20] WALSH M C,CHOI Y.Biology of the RANKL-RANK-OPG system in immunity,bone,and beyond[J].Front Immunol,2014,20(5):511-516.
[21] 王希丹,肖苏妹,陈裕明.广州地区中老年男性RANK/RANKL/OPG和WNT信号通路基因多态性与髋部骨强度的关联分析[J].生命科学研究,2018,22(2):143-148.
[22] 黄斌,秦汉兴,吕波,等.骨质疏松性骨折与OPG/RANK/RANKL的相关性研究[J].实用临床医药杂志,2016,20(19):51-54.
[23] SOPIEN R,RYNIO P,KUBALA E,et al.Denosumab-a new medication in the treatment of postmenopausal osteoporosis[J].Prz Menopauzalny,2017,16(3):75-78.
[24] 马涛,王通.运动对废用性骨质疏松大鼠骨代谢和破骨细胞分化OPG-RANKL-RANK系统的影响[J].中国运动医学杂志,2017,36(7):578-585.
[25] WEN Z H,TANG C C,CHANG Y C,et al.Calcitonin attenuates cartilage degeneration and nociception in an experimental rat model of osteoarthritis:role of TGF-β in chondrocytes[J].Sci Rep,2016,21(6):1-11.
[26] GINER M,MONTOYA M J,VáZQUEZ M A,et al.Differences in osteogenic and apoptotic genes between osteoporotic and osteoarthritic patients[J].BMC Musculoskelet Disord,2013,14(4):1471-1474.
[27] ZHU S,CHEN K,LAN Y,et al.Alendronate protects against articular cartilage erosion by inhibiting subchondral bone loss in ovariectomized rats[J].Bone,2013,53(2):340-349.
[28] 陈海霞,张开伟,马文娟,等.补肾活血汤干预骨质疏松并骨关节炎模型兔软骨多种细胞因子mRNA的表达[J].中国组织工程研究,2018,22(32):5123-5132.
[29] 郑兆宽,赵洪普,吕玉明,等.骨质疏松症与SD大鼠膝骨性关节炎的发病[J].中国组织工程研究,2018,22(32):5104-5109.